160 related articles for article (PubMed ID: 38406509)
21. Predictive value for increased activated factor XI activity in acute venous thromboembolism.
Nagy M; Robles AP; Visser M; Koeck T; Ten Cate V; Ten Cate-Hoek AJ; Schwers S; Heitmeier S; Ten Cate H; Wild PS; Spronk HMH
J Thromb Haemost; 2023 Jun; 21(6):1610-1622. PubMed ID: 37003466
[TBL] [Abstract][Full Text] [Related]
22. Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors.
Tripodi A; Ammollo CT; Semeraro F; Colucci M; Malchiodi E; Verrua E; Ferrante E; Arnaldi G; Trementino L; Padovan L; Chantarangkul V; Peyvandi F; Mantovani G
Endocrine; 2017 May; 56(2):298-307. PubMed ID: 27448294
[TBL] [Abstract][Full Text] [Related]
23. Genetic variation of the blood coagulation regulator tissue factor pathway inhibitor and venous thromboembolism among middle-aged and older adults: A population-based cohort study.
Manderstedt E; Lind-Halldén C; Halldén C; Elf J; Svensson PJ; Engström G; Melander O; Baras A; Lotta LA; Zöller B;
Res Pract Thromb Haemost; 2022 Oct; 6(7):e12842. PubMed ID: 36381289
[TBL] [Abstract][Full Text] [Related]
24. Thrombin Generation Assay in Hospitalized Nonsurgical Patients: A New Tool to Assess Venous Thromboembolism Risk?
Espitia O; Fouassier M; Hardouin JB; Pistorius MA; Agard C; Planchon B; Trossaert M; Pottier P
Clin Appl Thromb Hemost; 2017 Jan; 23(1):45-51. PubMed ID: 26259913
[TBL] [Abstract][Full Text] [Related]
25. Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study.
Fotiou D; Sergentanis TN; Papageorgiou L; Stamatelopoulos K; Gavriatopoulou M; Kastritis E; Psaltopoulou T; Salta S; Van Dreden P; Sangare R; Larsen AK; Terpos E; Elalamy I; Dimopoulos MA; Gerotziafas GT
Blood Cancer J; 2018 Nov; 8(11):102. PubMed ID: 30405097
[TBL] [Abstract][Full Text] [Related]
26. Does cell-free DNA promote coagulation and inhibit fibrinolysis in patients with unprovoked venous thromboembolism?
Medeiros SK; Emery B; Bhagirath V; Parpia S; Dwivedi DJ; Dwivedi NJ; Kearon C; Liaw PC
Thromb Res; 2020 Feb; 186():13-19. PubMed ID: 31838139
[TBL] [Abstract][Full Text] [Related]
27. Thalidomide-prednisone maintenance following autologous stem cell transplant for multiple myeloma: effect on thrombin generation and procoagulant markers in NCIC CTG MY.10.
Kovacs MJ; Davies GA; Chapman JA; Bahlis N; Voralia M; Roy J; Kouroukis CT; Chen C; Belch A; Reece D; Zhu L; Meyer RM; Shepherd L; Stewart KA
Br J Haematol; 2015 Feb; 168(4):511-7. PubMed ID: 25302852
[TBL] [Abstract][Full Text] [Related]
28. Screening and functional exploration of prothrombin Arg596 related mutations in Chinese venous thromboembolism patients.
Wu X; Li L; Ding Q; Wang X; Wu F; Wu W
J Clin Pathol; 2018 Jul; 71(7):614-619. PubMed ID: 29331940
[TBL] [Abstract][Full Text] [Related]
29. Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram.
Machlus KR; Colby EA; Wu JR; Koch GG; Key NS; Wolberg AS
Thromb Haemost; 2009 Nov; 102(5):936-44. PubMed ID: 19888532
[TBL] [Abstract][Full Text] [Related]
30. Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors.
Thibord F; Klarin D; Brody JA; Chen MH; Levin MG; Chasman DI; Goode EL; Hveem K; Teder-Laving M; Martinez-Perez A; Aïssi D; Daian-Bacq D; Ito K; Natarajan P; Lutsey PL; Nadkarni GN; de Vries PS; Cuellar-Partida G; Wolford BN; Pattee JW; Kooperberg C; Braekkan SK; Li-Gao R; Saut N; Sept C; Germain M; Judy RL; Wiggins KL; Ko D; O'Donnell CJ; Taylor KD; Giulianini F; De Andrade M; Nøst TH; Boland A; Empana JP; Koyama S; Gilliland T; Do R; Huffman JE; Wang X; Zhou W; Manuel Soria J; Carlos Souto J; Pankratz N; Haessler J; Hindberg K; Rosendaal FR; Turman C; Olaso R; Kember RL; Bartz TM; Lynch JA; Heckbert SR; Armasu SM; Brumpton B; Smadja DM; Jouven X; Komuro I; Clapham KR; Loos RJF; Willer CJ; Sabater-Lleal M; Pankow JS; Reiner AP; Morelli VM; Ridker PM; Vlieg AVH; Deleuze JF; Kraft P; Rader DJ; ; Min Lee K; Psaty BM; Heidi Skogholt A; Emmerich J; Suchon P; Rich SS; Vy HMT; Tang W; Jackson RD; Hansen JB; Morange PE; Kabrhel C; Trégouët DA; Damrauer SM; Johnson AD; Smith NL
Circulation; 2022 Oct; 146(16):1225-1242. PubMed ID: 36154123
[TBL] [Abstract][Full Text] [Related]
31. The effect of beta-receptor blockade on factor VIII levels and thrombin generation in patients with venous thromboembolism.
Schönauer V; Giannini S; Christ G; Quehenberger P; Bieglmayer C; Stain M; Kyrle PA; Weltermann A
Thromb Haemost; 2003 May; 89(5):837-41. PubMed ID: 12719781
[TBL] [Abstract][Full Text] [Related]
32. Common hemostasis and inflammation gene variants and venous thrombosis in older adults from the Cardiovascular Health Study.
Reiner AP; Lange LA; Smith NL; Zakai NA; Cushman M; Folsom AR
J Thromb Haemost; 2009 Sep; 7(9):1499-505. PubMed ID: 19552680
[TBL] [Abstract][Full Text] [Related]
33. Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies.
Joly B; Barbay V; Borg JY; Le Cam-Duchez V
Thromb Res; 2013 Sep; 132(3):386-91. PubMed ID: 23962423
[TBL] [Abstract][Full Text] [Related]
34. Proteomic insights into modifiable risk of venous thromboembolism and cardiovascular comorbidities.
Yuan S; Xu F; Zhang H; Chen J; Ruan X; Li Y; Burgess S; Åkesson A; Li X; Gill D; Larsson SC
J Thromb Haemost; 2024 Mar; 22(3):738-748. PubMed ID: 38029854
[TBL] [Abstract][Full Text] [Related]
35. Translational insights into mechanisms underlying residual venous obstruction and the role of factor XI, P-selectin and GPVI in recurrent venous thromboembolism.
Iding AFJ; Kremers BMM; Nagy M; Pallares Robles A; Ten Cate H; Spronk HMH; Ten Cate-Hoek AJ
Thromb Res; 2023 Jan; 221():58-64. PubMed ID: 36473362
[TBL] [Abstract][Full Text] [Related]
36. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
37. Activated Factor XI is Increased in Plasma in Response to Surgical Trauma but not to Recombinant Activated FVII-Induced Thrombin Formation.
Rühl H; Friemann AM; Reda S; Schwarz N; Winterhagen FI; Berens C; Müller J; Oldenburg J; Pötzsch B
J Atheroscler Thromb; 2022 Jan; 29(1):82-98. PubMed ID: 33298665
[TBL] [Abstract][Full Text] [Related]
38. Oral Contraceptive Types in Relation to ABO Blood Groups Among Saudi Women of Different Reproductive Age Groups and Impact on Venous Thromboembolism.
Mohamed ABO; Al-Ama N; Al Kreathy H; Ahmed KHB; Al Amri T; Harakeh S; Mousa SA; De Laat B
Clin Appl Thromb Hemost; 2020; 26():1076029620966051. PubMed ID: 33112684
[TBL] [Abstract][Full Text] [Related]
39. Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.
Colwell CW; Berkowitz SD; Davidson BL; Lotke PA; Ginsberg JS; Lieberman JR; Neubauer J; McElhattan JL; Peters GR; Francis CW
J Thromb Haemost; 2003 Oct; 1(10):2119-30. PubMed ID: 14521593
[TBL] [Abstract][Full Text] [Related]
40. The endogenous thrombin potential and the risk of venous thromboembolism.
Tripodi A; Martinelli I; Chantarangkul V; Battaglioli T; Clerici M; Mannucci PM
Thromb Res; 2007; 121(3):353-9. PubMed ID: 17560633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
